サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413067

多重検出免疫測定法市場：技術、アッセイタイプ、用途、エンドユーザー別-2024-2030年世界予測

Multiplex Detection Immunoassays Market by Technique, Assay Type (Antibody Arrays, Bead-based assay, Blends Protein Arrays ), Application, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
多重検出免疫測定法市場：技術、アッセイタイプ、用途、エンドユーザー別-2024-2030年世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

多重検出免疫測定法市場規模は2023年に21億1,000万米ドルと推計され、2024年には22億5,000万米ドルに達し、CAGR 6.92%で2030年には33億7,000万米ドルに達すると予測されます。

多重検出免疫測定法の世界市場

主な市場の統計
基準年[2023］ 21億1,000万米ドル
予測年[2024］ 22億5,000万米ドル
予測年 [2030] 33億7,000万米ドル
CAGR（%） 6.92%
多重検出免疫測定法 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは多重検出免疫測定法市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、多重検出免疫測定法市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-多重検出免疫測定法市場の市場規模および予測は？

2-多重検出免疫測定法市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-多重検出免疫測定法市場における技術動向と規制の枠組みは？

4-多重検出免疫測定法市場における主要ベンダーの市場シェアは？

5-多重検出免疫測定法市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で慢性疾患や感染症の発生率が上昇
      • 個別化された精密医療への関心の高まり
      • 医薬品開発および調査活動に対する政府の有利な資金提供
    • 抑制要因
      • 関連する複雑さと機器のコストの高さ
    • 機会
      • ヘルスケアおよび製薬業界における先端技術の出現
      • 臨床診断における自動化機器の急速な開発
    • 課題
      • 熟練した経験豊富な対象分野の専門家の不足
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 多重検出免疫測定法市場：技術別

  • バイオセンサーベースの技術
  • 核酸ベースの技術
  • タンパク質ベースの技術

第7章 多重検出免疫測定法市場アッセイタイプ別

  • 抗体アレイ
  • ビーズベースのアッセイ
  • タンパク質アレイのブレンド（多重化ELISA）
  • 磁気ビーズベース
  • 非磁性ビーズベース
  • 平面アッセイ

第8章 多重検出免疫測定法市場：用途別

  • 病気の検査
  • 食品汚染検査
  • 研究開発
  • 獣医疾患検査

第9章 多重検出免疫測定法市場：エンドユーザー別

  • 学術調査機関
  • バイオテクノロジー企業
  • 臨床調査機関
  • 診断センター
  • 食品および飲料会社
  • 製薬会社

第10章 南北アメリカの多重検出免疫測定法市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の多重検出免疫測定法市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの多重検出免疫測定法市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abcam PLC
    • Advanced Cell Diagnostics, Inc.
    • Aehealth Limited
    • Assay Genie
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Charles River Laboratories
    • Elabscience Biotechnology Inc.
    • Fortis Life Sciences LLC
    • Illumina Inc.
    • Luminex Corporation by DiaSorin S.p.A.
    • Merck KGaA
    • Meso Scale Diagnostics, LLC
    • PerkinElmer Inc.
    • Promega Corporation
    • Qiagen N.V.
    • Quansys Biosciences Inc.
    • Quanterix Corporation
    • R&D Systems, Inc.
    • Randox Laboratories Ltd.
    • Sartorius AG
    • Scienion by Bico Company
    • Scorpius BioManufacturing
    • Seegene Inc.
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. MULTIPLEX DETECTION IMMUNOASSAYS MARKET DYNAMICS
  • FIGURE 7. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 8. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 6. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOSENSOR-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PROTEIN-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ANTIBODY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BEAD-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BLENDS PROTEIN ARRAYS (MULTIPLEXED ELISA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NON-MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PLANAR ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD CONTAMINATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY VETERINARY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD & BEVERAGES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 197. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. MULTIPLEX DETECTION IMMUNOASSAYS MARKET LICENSE & PRICING
目次
Product Code: MRR-FF012EDC38DC

[198 Pages Report] The Multiplex Detection Immunoassays Market size was estimated at USD 2.11 billion in 2023 and expected to reach USD 2.25 billion in 2024, at a CAGR 6.92% to reach USD 3.37 billion by 2030.

Global Multiplex Detection Immunoassays Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.11 billion
Estimated Year [2024] USD 2.25 billion
Forecast Year [2030] USD 3.37 billion
CAGR (%) 6.92%
Multiplex Detection Immunoassays Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Multiplex Detection Immunoassays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Multiplex Detection Immunoassays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Multiplex Detection Immunoassays Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Advanced Cell Diagnostics, Inc., Aehealth Limited, Assay Genie, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories, Elabscience Biotechnology Inc., Fortis Life Sciences LLC, Illumina Inc., Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Meso Scale Diagnostics, LLC, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Quansys Biosciences Inc., Quanterix Corporation, R&D Systems, Inc., Randox Laboratories Ltd., Sartorius AG, Scienion by Bico Company, Scorpius BioManufacturing, Seegene Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiplex Detection Immunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technique
    • Biosensor-Based Techniques
    • Nucleic Acid-Based Techniques
    • Protein-Based Techniques
  • Assay Type
    • Antibody Arrays
    • Bead-based assay
    • Blends Protein Arrays (Multiplexed ELISA)
    • Magnetic Bead-based
    • Non-magnetic Bead-based
    • Planar Assay
  • Application
    • Disease Testing
    • Food Contamination Testing
    • Research and Development
    • Veterinary Disease Testing
  • End-User
    • Academic Research Institutes
    • Biotechnology Companies
    • Clinical Research Organizations
    • Diagnostic Centers
    • Food & Beverages Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Multiplex Detection Immunoassays Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Multiplex Detection Immunoassays Market?

3. What are the technology trends and regulatory frameworks in the Multiplex Detection Immunoassays Market?

4. What is the market share of the leading vendors in the Multiplex Detection Immunoassays Market?

5. Which modes and strategic moves are suitable for entering the Multiplex Detection Immunoassays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Multiplex Detection Immunoassays Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of chronic and infectious diseases across the globe
      • 5.1.1.2. Growing preference for personalized -precision medicines
      • 5.1.1.3. Favorable government funding for drug development and research activities
    • 5.1.2. Restraints
      • 5.1.2.1. Associated complexity and high cost of equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of advanced technologies in the healthcare and pharmaceutical industry
      • 5.1.3.2. Rapid development of automated instruments in clinical diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled and experienced subject matter experts
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Multiplex Detection Immunoassays Market, by Technique

  • 6.1. Introduction
  • 6.2. Biosensor-Based Techniques
  • 6.3. Nucleic Acid-Based Techniques
  • 6.4. Protein-Based Techniques

7. Multiplex Detection Immunoassays Market, by Assay Type

  • 7.1. Introduction
  • 7.2. Antibody Arrays
  • 7.3. Bead-based assay
  • 7.4. Blends Protein Arrays (Multiplexed ELISA)
  • 7.5. Magnetic Bead-based
  • 7.6. Non-magnetic Bead-based
  • 7.7. Planar Assay

8. Multiplex Detection Immunoassays Market, by Application

  • 8.1. Introduction
  • 8.2. Disease Testing
  • 8.3. Food Contamination Testing
  • 8.4. Research and Development
  • 8.5. Veterinary Disease Testing

9. Multiplex Detection Immunoassays Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Clinical Research Organizations
  • 9.5. Diagnostic Centers
  • 9.6. Food & Beverages Companies
  • 9.7. Pharmaceutical Companies

10. Americas Multiplex Detection Immunoassays Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Multiplex Detection Immunoassays Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Multiplex Detection Immunoassays Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abcam PLC
    • 14.1.2. Advanced Cell Diagnostics, Inc.
    • 14.1.3. Aehealth Limited
    • 14.1.4. Assay Genie
    • 14.1.5. Becton, Dickinson and Company
    • 14.1.6. Bio-Rad Laboratories, Inc.
    • 14.1.7. Charles River Laboratories
    • 14.1.8. Elabscience Biotechnology Inc.
    • 14.1.9. Fortis Life Sciences LLC
    • 14.1.10. Illumina Inc.
    • 14.1.11. Luminex Corporation by DiaSorin S.p.A.
    • 14.1.12. Merck KGaA
    • 14.1.13. Meso Scale Diagnostics, LLC
    • 14.1.14. PerkinElmer Inc.
    • 14.1.15. Promega Corporation
    • 14.1.16. Qiagen N.V.
    • 14.1.17. Quansys Biosciences Inc.
    • 14.1.18. Quanterix Corporation
    • 14.1.19. R&D Systems, Inc.
    • 14.1.20. Randox Laboratories Ltd.
    • 14.1.21. Sartorius AG
    • 14.1.22. Scienion by Bico Company
    • 14.1.23. Scorpius BioManufacturing
    • 14.1.24. Seegene Inc.
    • 14.1.25. Thermo Fisher Scientific Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing